WO2006070802A1 - Patch transdermique et procédé de fabrication dudit patch - Google Patents

Patch transdermique et procédé de fabrication dudit patch Download PDF

Info

Publication number
WO2006070802A1
WO2006070802A1 PCT/JP2005/023899 JP2005023899W WO2006070802A1 WO 2006070802 A1 WO2006070802 A1 WO 2006070802A1 JP 2005023899 W JP2005023899 W JP 2005023899W WO 2006070802 A1 WO2006070802 A1 WO 2006070802A1
Authority
WO
WIPO (PCT)
Prior art keywords
release paper
hole
transdermal
powdery
base material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2005/023899
Other languages
English (en)
Japanese (ja)
Inventor
Tsutomu Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGURU Co Ltd
Original Assignee
AGURU Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGURU Co Ltd filed Critical AGURU Co Ltd
Publication of WO2006070802A1 publication Critical patent/WO2006070802A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Definitions

  • the present invention relates to a transdermal patch that can be easily manufactured while reducing muscle pain and the like, and a method for manufacturing the same.
  • a pellet-shaped permanent magnet or the like is attached to an adhesive sheet, and this is attached to a painful part and released from the permanent magnet.
  • the permanent magnet is a hard magnetic iron and steel material, there is a problem that the patient feels uncomfortable when the permanent magnet is attached to the affected area.
  • transdermal bonding agent 0
  • Patent Document 1 JP 2002-224228
  • Patent Document 2 JP 2003-292446 ⁇ -Disclosure of Invention
  • powdery transdermal agent having an analgesic action for example, the power that magnesium carbonate powder is known. While this magnesium carbonate powder has a high analgesic action, its amount is too large. And, the affected part on which the sticking is made is uncomfortable depending on the part. In some cases, powdered transdermal agents with analgesic action must be fixed in a certain amount and affixed to the adhesive sheet. In addition to the above problems, their production is more difficult.
  • the present invention is intended to solve the problem to be solved, and can be easily and stably attached to an adhesive sheet without kneading a powdery transdermal agent into the adhesive.
  • a skin patch and a method for producing the same are provided.
  • the transdermal patch according to claim 1 includes a plurality of first release papers having a plurality of holes formed in a row and a size sufficiently larger than the holes, each having an adhesive surface formed on one side.
  • the base material piece is configured by combining the second release paper that is pasted on the back surface of the first release paper, and each of the plurality of base material pieces closes the hole of the first release paper.
  • a powdery transdermal agent is applied to the portion of the adhesive surface that is adhered to the surface of the first release paper and exposed from the hole on the back surface of the first release paper.
  • the second release paper is attached to the back surface of the first release paper so as to block the portion of the first release paper to which the powdery transdermal agent is exposed from the hole. It becomes.
  • the powdered transdermal agent is applied to the adhesive part exposed from the hole on the back surface of the first release paper without kneading the adhesive, and therefore, the production can be facilitated.
  • the transdermal patch according to claim 2 is the method according to claim 1, wherein the hole portion of the first release paper is formed with a cut from the side edge of the first release paper to the hole portion.
  • the release paper can be easily peeled off by simply pinching the cut without forming a nail on the periphery of the release paper.
  • the base piece can be easily removed.
  • the transdermal patch according to claim 3 is the powder transdermal agent according to any one of claims 1 and 2, comprising magnesium carbonate powder as a main component.
  • the powdered transdermal agent is composed mainly of magnesium carbonate powder, and this magnesium carbonate powder is brought into contact with the skin of a human body, etc., so that a high analgesic effect can be obtained.
  • magnesium has the action of suppressing the transmission of the neuromuscular junction in the peripheral nervous system, and its mechanism of action mainly acts on nerve endings to release the neurotransmitter acetylcholine.
  • Has the property of reducing It also activates the enzyme ATPase and acts on the ATPaseca S ion transport mechanism to maintain the gradient of potassium ion concentration related to muscle pain.
  • magnesium carbonate powder which is safe even in the powder state, is the main component of the transdermal agent.
  • the transdermal patch according to claim 4 is the powdery transdermal agent according to any one of claims 1 to 3, wherein the magnesium carbonate powder is one or more of copper, aluminum, silver, and gold. The metal powder is blended.
  • This product has an effect of appropriately mitigating the uncomfortable feeling caused by the magnesium carbonate powder.
  • the magnesium carbonate powder has a strong analgesic effect, depending on the symptoms, the magnesium carbonate powder alone may be too strong.
  • the magnesium carbonate powder is mixed with one or more metal powders of copper, aluminum, silver, and gold. Therefore, the irritation caused by the magnesium carbonate powder can be appropriately mitigated.
  • any one of them means copper, aluminum, silver, and gold metal powders. If these metal powders are mixed with magnesium carbonate powder according to the application, this magnesium carbonate is used. Experiments have shown that the stimulation of shim powder can be adequately mitigated, and that effects can be achieved depending on the application.
  • Metal powders other than those described above, for example, metal powders such as titanium, can be blended, but their blending amount, action, and effect are currently under experiment.
  • the pot by stimulating the pot, it acts on each part of the body related to the pot, for example, by sticking it on the ear pot, sagging facial wrinkles, wrinkles, eye size, Effects such as bust-up, abdominal tightening, and hip-up can be obtained.
  • the type and amount of the metal powder to be mixed may be changed. Specifically, the metal powder of aluminum and copper (or gold) is added to the magnesium powder. When formulated in proportions, it has been shown to be effective in alleviating chronic pain and shaping the body.
  • the transdermal patch of the present application can also be used as an esthetic product such as a beautiful face.
  • an adhesive surface is formed on one side of the first release paper in which a plurality of holes are formed in a row, and is sufficiently more than the holes.
  • a plurality of substrate pieces formed in a large size are adhered so that the adhesive surface of each substrate piece adheres to the surface of the first release paper and closes one of the holes, and then After the powdery transdermal agent is applied to the adhesive surface of the base material piece exposed from the hole on the back surface of the first release paper, the hole is closed so that the first release paper is closed.
  • a second release paper is pasted on the back side.
  • a base material piece is pasted so as to close the hole of the first release paper, and the opening of the hole is exposed, and the powdery transcutaneous material is exposed on the back surface of the first release paper. Since the agent is applied, the powdery transdermal agent can be stably adhered to the adhesive surface of the substrate piece from the opening of each hole without spraying.
  • a second release paper is attached to the back surface of the first release paper so as to close the hole. If a powdery transdermal agent is applied, the transdermal patch can be easily mass-produced with simple equipment.
  • an adhesive surface is formed on one side of the first release paper in which a plurality of hole portions are formed in a row, and more sufficiently than the hole portions.
  • a plurality of substrate pieces formed in a large size are adhered so that the adhesive surface of each substrate piece adheres to the surface of the first release paper and closes one of the holes, and then After pasting the transdermal agent formed in a solid form on the adhesive surface of the base material piece exposed from the hole on the back surface of the first release paper, the holes were closed.
  • the second release paper is pasted on the back side of the first release paper.
  • a piece of base material is pasted so as to close the hole of the first release paper, and the solid skin is placed on the back surface of the first release paper exposing the opening of the hole. Since the agent is adhered, the adhesive force of the base material piece can be stably adhered to the opening force of each hole without spraying the transdermal agent.
  • the solid transdermal agent can be easily produced, for example, by adding a binder to a powdered transdermal agent and press-molding it into a desired shape. If the skin is attached so as to close the hole, the transdermal patch can be easily mass-produced with simple equipment.
  • the present invention has the following effects.
  • the powdery transdermal agent is applied to the adhesive part exposed from the hole on the back surface of the first release paper without kneading the adhesive, Can be done easily.
  • the cut from the side edge of the release paper to the hole is formed, the cut is made without raising the nail around the periphery of the release paper.
  • the release paper can be easily peeled off and the base piece can be easily removed.
  • the powdery transdermal agent comprises magnesium carbonate powder. Because it is the main ingredient and this magnesium carbonate powder comes into contact with the skin of a human body, etc., a high analgesic effect is obtained.
  • the powdery transdermal agent has magnesium carbonate powder mixed with one or more metal powders of copper, aluminum, silver, and gold. Therefore, there is an effect of appropriately mitigating the uncomfortable feeling caused by the magnesium carbonate powder. In addition to the analgesic action of magnesium carbonate powder, a synergistic effect of the combination of blended metal powders can be obtained.
  • the acupuncture point acts on each part of the body related to the acupuncture point. It can be active, improve facial wrinkle sagging and wrinkles, prevent wrinkle sagging, bust up, tighten the abdomen, and increase hips.
  • the base material piece is pasted so as to block the hole of the first release paper, and the opening of the hole is exposed. Since the powdery transdermal agent is applied to the back surface of the release paper, the adhesive force of the substrate piece can be stably adhered to the opening force of each hole without spraying the powdery transdermal agent.
  • a second release paper is attached to the back surface of the first release paper so as to close the hole. If a powdery transdermal agent is applied, the transdermal patch can be easily mass-produced with simple equipment.
  • the base material piece is pasted so as to block the hole of the first release paper, and the opening of the hole is exposed. Since the solid transdermal agent is attached to the back surface of the release paper, it can be stably adhered to the adhesive surface of the base material piece from the opening of each hole without spraying the transdermal agent.
  • the transdermal adhesive when the pores are stuck with a solid transdermal agent, the transdermal adhesive can be easily mass-produced with simple equipment.
  • FIG. 1 is a perspective view schematically showing an embodiment of a transdermal patch A and a method for producing the same according to the present invention.
  • FIG. 2 is a perspective view of the essential part of a part of the transdermal patch A shown in FIG. 1, partially enlarged.
  • FIG. 3 is a partially enlarged cross-sectional view of a part of the transdermal patch A shown in FIG. Explanation of symbols
  • FIG. 1 is a perspective view schematically illustrating an embodiment of the transdermal patch A and a method for producing the same according to the present invention
  • FIG. 2 is a part of the transdermal patch A shown in FIG.
  • FIG. 3 is a partially enlarged cross-sectional view of a part of the transdermal patch A shown in FIG.
  • this transdermal patch A first, a first release paper 1 in which a plurality of hole portions 11 are formed in a row, an adhesive surface 21 formed on one side, and sufficiently more than the hole portions 11 are formed. Using a plurality of base material pieces 2 formed in a large size, each base material piece 2 is covered with the surface 12 of the first release paper 1 so that the adhesive surface 21 closes one of the holes 11. Adhere to.
  • the first release paper 1 uses a thin-film resin sheet or paper sheet formed in a rectangular shape, and the surface 12 can be attached to at least the adhesive surface 21 of the base piece 2. And the base material piece 2 after this sticking is provided with the release property which can peel.
  • circular hole portions 11 are opened at equal intervals, and a plurality of hole portions 11 are formed in a row.
  • the holes 11 arranged in two rows are illustrated in two rows, but the number of rows and the number of rows is the outer shape of the first release paper 1 or the base piece. It is selected as appropriate according to the size of 2.
  • the shape of the hole 11 can be formed in various shapes such as a circle and a square.
  • the surface area of the hole 11 is a powdery transdermal agent component to be applied to the hole 11 described later. It is selected according to
  • the base piece 2 is formed of a deformable sheet material such as a non-woven fabric in a similar shape sufficiently larger than the hole 11, and each base piece 2 is formed as shown in the right diagram of FIG.
  • the adhesive surface 21 is stuck to the surface 12 of the first release paper 1 so as to block one side of the hole 11.
  • the first release paper 1 is turned upside down and exposed through the hole 11 on the back surface 13 of the first release paper 1, that is, the base piece 2
  • the powdery transdermal agent 3 is applied with a brush 4 or the like toward the substantially central portion of the adhesive surface 21 of the brush.
  • the powdered transdermal agent 3 is embedded in the hole 11 with the brush 4 or the like, and then the brush.
  • the powdery transdermal agent 3 is mainly composed of magnesium carbonate powder, a high analgesic action can be obtained, and the powdery transdermal agent 3 can be used in accordance with the diameter and depth of each hole 11. A certain amount can be stably applied to the adhesive surface 21 of the piece 2.
  • the strength of the analgesic action can be adjusted by the size of the opening of the hole 11.
  • the magnesium carbonate powder has a different ionic tendency such as copper, aluminum, silver, gold, etc. Any one or more metal powders are used.
  • the amount of these metal powders of copper, aluminum, silver, and gold, the type of metal powder to be blended, etc. are to an extent that alleviates the analgesic action or effects on the affected area, such as muscle tension, diet, etc. It is selected according to the effect.
  • transdermal agent 3 containing the same amount of copper powder (or gold powder) and aluminum powder as the magnesium carbonate powder to the acupuncture points or stimulation points of the ear, there is a whole body tightening effect.
  • it has been confirmed that it is also effective for diets such as facial wrinkle sagging and wrinkle improvement, wrinkle sagging prevention, bast up, abdominal tightening, and hip up.
  • the transdermal agent 3 formed in a solid state is attached to the hole 11 on the back surface 13 of the first release paper 1, and the hole 11 is attached. It is also possible to close it.
  • the solid transdermal agent 3 can be easily produced by, for example, adding a binder to the powdered transdermal agent 3 and then press-molding it into a desired shape with an existing molding machine or the like. it can.
  • dust or the like adheres to the powdery transdermal agent 3 exposed from the hole 11.
  • a transparent thin film sheet may be used if it is not adhered to the exposed powdery transdermal agent 3 and is attached to the back surface 13 of the first release paper.
  • the film sheet is formed in the same outer shape as the first release paper 1, and this film sheet is attached to the back surface 13 of the first release paper.
  • the second release paper 5 may be formed with perforations so that it can be divided according to each base piece 2.
  • the second release paper 5 may be a powdery warp. It may be attached individually so as to protect only the skin 3 part.
  • transdermal patch A of the present invention thus formed is used in the following manner.
  • one base piece 2 is peeled from the surface 12 of the first release paper 1, and the powdery transdermal agent 3 applied to the adhesive surface 21 of the base piece 2 is applied to the patient.
  • the adhesive surface 21 of the base piece 2 is pressed against the patient's skin while being placed on a pot or the like.
  • the necessary number of base material pieces 2 are sequentially peeled from the surface 12 of the first release paper 1, and the adhesive surface 21 of the base material piece 2 is pressed against the patient's skin and attached.
  • magnesium carbonate powder In addition, moderate analgesic action by the magnesium carbonate powder is given to the patient, or in addition to this analgesic action, various other metal powders can be obtained to obtain the same various effects.
  • the solid transdermal agent 3 moderately stimulates the patient's acupuncture points and obtains the same effect as the powdery transdermal agent 3. be able to.
  • the substrate piece 2 can be easily peeled from the surface 12 of the first release paper 1.
  • the present invention can be effectively used as a transdermal patch that can be easily and stably affixed to a pressure-sensitive adhesive sheet without scattering a powdery powdered transdermal drug.

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L’invention concerne un patch transdermique que l’on peut coller facilement et de manière stable sur une feuille adhésive sensible à la pression tout en empêchant toute dispersion d’un médicament transdermique poudreux, et un procédé de fabrication dudit patch. Le patch transdermique comprend un premier papier détachable (1) ayant de multiples trous (11) alignés sur celui-ci, de multiples pièces de substrat (2) de taille suffisamment plus grande que les trous (11) et présentant une face adhésive sensible à la pression (21) formée sur une face, et un second papier détachable (5) collé à la face verso (12) du premier papier détachable (1). A la surface (13) du premier papier détachable (1) est collée la face adhésive sensible à la pression (21) de chacune des pièces de substrat (2) de sorte que les multiples pièces de substrat (2) recouvrent respectivement les trous (11). Sur la face verso (12) du premier papier détachable (1), les pièces de la face adhésive sensible à la pression (21) des pièces de substrat (2) qui sont exposées à partir des trous (11) sont enduites d’un médicament transdermique poudreux (3). Le second papier détachable (5) est collé à la face verso (13) du premier papier détachable (1) de telle sorte que les pièces exposées à partir des trous (11) et enduites du médicament transdermique poudreux (3) sont recouvertes.
PCT/JP2005/023899 2004-12-27 2005-12-27 Patch transdermique et procédé de fabrication dudit patch Ceased WO2006070802A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004377776A JP3986525B2 (ja) 2004-12-27 2004-12-27 経皮貼り剤及びその製造方法
JP2004-377776 2004-12-27

Publications (1)

Publication Number Publication Date
WO2006070802A1 true WO2006070802A1 (fr) 2006-07-06

Family

ID=36614914

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/023899 Ceased WO2006070802A1 (fr) 2004-12-27 2005-12-27 Patch transdermique et procédé de fabrication dudit patch

Country Status (3)

Country Link
JP (1) JP3986525B2 (fr)
KR (1) KR100992041B1 (fr)
WO (1) WO2006070802A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020501694A (ja) * 2016-12-13 2020-01-23 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 皮膚用接着剤塗布用窓を備えた血管アクセスデバイスのための固定用手当用品
US11911570B2 (en) 2017-04-07 2024-02-27 Becton, Dickinson And Company Catheter securement device with window

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625275D0 (en) * 2006-12-19 2007-01-24 Glaxo Group Ltd Novel process
CN107638421A (zh) * 2016-07-21 2018-01-30 天津世济生物工程有限公司 一种高透气性膏药药芯
JP2019137621A (ja) * 2018-02-07 2019-08-22 花王株式会社 皮膚貼付用炭酸ガス供給シート及び皮膚貼付用炭酸ガス供給シートキット
KR102372815B1 (ko) * 2020-03-13 2022-03-10 한국기계연구원 피부 부착 박막의 제조를 위한 성형몰드 및 이를 이용한 피부 부착 박막 제조 방법

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5684822U (fr) * 1979-12-03 1981-07-08
JPS56170231U (fr) * 1980-05-20 1981-12-16
JPS571829U (fr) * 1980-05-30 1982-01-07
JPS59130212A (ja) * 1983-01-14 1984-07-26 Shinzo Arai 磁気はり薬の製造法
JPH0268824U (fr) * 1988-11-14 1990-05-24
JPH03115629U (fr) * 1990-03-09 1991-11-29
JPH0546921U (ja) * 1991-11-20 1993-06-22 直樹 宮口 鎮痛消炎湿布剤
JP2003277254A (ja) * 2002-03-19 2003-10-02 Seiichi Yazaki 外用貼付薬
JP2003290273A (ja) * 2002-03-29 2003-10-14 Sansei:Kk パッチテスト・テープ
JP2003292446A (ja) * 2002-04-03 2003-10-15 Tsutomu Kawamura 炭酸マグネシウム治療器具

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272922A (fr) 1986-06-03 1990-08-21 Peter William Berry Dispositif d'administration de medicaments, preparation et utilisation
US5503844A (en) 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
US5902260A (en) 1997-03-14 1999-05-11 Hollister Incorporated Thin film wound dressing with stretchable foraminous backing layer
DE19923427A1 (de) 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5684822U (fr) * 1979-12-03 1981-07-08
JPS56170231U (fr) * 1980-05-20 1981-12-16
JPS571829U (fr) * 1980-05-30 1982-01-07
JPS59130212A (ja) * 1983-01-14 1984-07-26 Shinzo Arai 磁気はり薬の製造法
JPH0268824U (fr) * 1988-11-14 1990-05-24
JPH03115629U (fr) * 1990-03-09 1991-11-29
JPH0546921U (ja) * 1991-11-20 1993-06-22 直樹 宮口 鎮痛消炎湿布剤
JP2003277254A (ja) * 2002-03-19 2003-10-02 Seiichi Yazaki 外用貼付薬
JP2003290273A (ja) * 2002-03-29 2003-10-14 Sansei:Kk パッチテスト・テープ
JP2003292446A (ja) * 2002-04-03 2003-10-15 Tsutomu Kawamura 炭酸マグネシウム治療器具

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020501694A (ja) * 2016-12-13 2020-01-23 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 皮膚用接着剤塗布用窓を備えた血管アクセスデバイスのための固定用手当用品
JP7088930B2 (ja) 2016-12-13 2022-06-21 ベクトン・ディキンソン・アンド・カンパニー 皮膚用接着剤塗布用窓を備えた血管アクセスデバイスのための固定用手当用品
US11395905B2 (en) 2016-12-13 2022-07-26 Becton, Dickinson And Company Securement dressing for vascular access device with skin adhesive application window
US11911570B2 (en) 2017-04-07 2024-02-27 Becton, Dickinson And Company Catheter securement device with window

Also Published As

Publication number Publication date
KR20070091338A (ko) 2007-09-10
JP2006182700A (ja) 2006-07-13
JP3986525B2 (ja) 2007-10-03
KR100992041B1 (ko) 2010-11-04

Similar Documents

Publication Publication Date Title
US10821297B2 (en) Kit and method for topical delivery of benefits
US20050187580A1 (en) Current producing surface
JP2023143916A (ja) 片頭痛発作の急性期非侵襲性治療のための外部三叉神経刺激
KR20120091335A (ko) 갈바닉 피부 치료 장치
US20230120384A1 (en) Menthol- and magnesium-infused kinesiology tape
WO2006070802A1 (fr) Patch transdermique et procédé de fabrication dudit patch
TW200738287A (en) Nicotine transdermal delivery system
KR20100005091U (ko) 뜸 기능을 갖는 자기 경혈 패치
JP3049245U (ja) 治療器
KR102202094B1 (ko) 장식부의 교체가 가능한 이침
JP3226110U (ja) 皮膚面貼付具
JP3153979U (ja) 健康用部材
JP2001187155A (ja) トルマリンを含む磁気治療シート
CN208958490U (zh) 一种粘贴型磁性眼睑闭合医疗装置
JP3155819U (ja) 足裏貼着用加圧治療具
JPS61293463A (ja) 治療用具
JP3169703U (ja) 装飾薬効シート
JP3030009U (ja) 治療用圧迫刺激具
JPH09103505A (ja) 磁気治療シートおよびその製造方法
JPH1147225A (ja) 皮膚刺激用貼付材
JP3043319U (ja) 整体促進具
JPS5831554Y2 (ja) 皮膚刺激治療器
JP3062206U (ja) 貼付用湿布用具
JPH0371906B2 (fr)
JP3030552U (ja) 医療器具

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1020077016326

Country of ref document: KR

122 Ep: pct application non-entry in european phase

Ref document number: 05822702

Country of ref document: EP

Kind code of ref document: A1